Compounds > sarkosyl
Page last updated: 2024-08-18

sarkosyl and Tauopathies

sarkosyl has been researched along with Tauopathies in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akiyama, H; Arai, T; Arima, K; Hasegawa, M; Iwatsubo, T; Kametani, F; Mann, DMA; Masuda-Suzukake, M; Murayama, S; Nonaka, T; Robinson, A; Saito, Y; Taniguchi-Watanabe, S; Tarutani, A; Yoshida, M1
Iqbal, K; Korenova, M; Kovacech, B; Novak, M; Zilka, N1
DeTure, M; Dickson, DW; Hutton, M; Lewis, J; McGowan, E; Sahara, N; Yen, SH1
Dickson, D; Hutton, M; Ishizawa, T; Lewis, J; McGowan, E; Sahara, N; Vega, IE; Yen, SH1
Biernat, J; Bujard, H; Drexler, D; Eckermann, K; Khlistunova, I; Mandelkow, E; Mandelkow, EM; Mocanu, MM; Nissen, A; Petrova, O; Rune, G; Schönig, K; Zhou, L1

Other Studies

5 other study(ies) available for sarkosyl and Tauopathies

ArticleYear
Biochemical classification of tauopathies by immunoblot, protein sequence and mass spectrometric analyses of sarkosyl-insoluble and trypsin-resistant tau.
    Acta neuropathologica, 2016, Volume: 131, Issue:2

    Topics: Aged; Aged, 80 and over; Amino Acid Sequence; Brain; Brain Chemistry; Female; Humans; Immunoblotting; Male; Mass Spectrometry; Microscopy, Immunoelectron; Middle Aged; Protein Conformation; Sarcosine; Sequence Analysis, Protein; tau Proteins; Tauopathies; Trypsin

2016
CSF phospho-tau correlates with behavioural decline and brain insoluble phospho-tau levels in a rat model of tauopathy.
    Acta neuropathologica, 2010, Volume: 119, Issue:6

    Topics: Animals; Brain; Detergents; Disease Models, Animal; Disease Progression; Humans; Longitudinal Studies; Phosphorylation; Rats; Rats, Transgenic; Sarcosine; Severity of Illness Index; tau Proteins; Tauopathies

2010
Assembly of tau in transgenic animals expressing P301L tau: alteration of phosphorylation and solubility.
    Journal of neurochemistry, 2002, Volume: 83, Issue:6

    Topics: Age Factors; Amino Acid Substitution; Animals; Binding Sites; Brain; Brain Chemistry; Detergents; Disease Models, Animal; Disease Progression; Electrophoresis, Polyacrylamide Gel; Female; Humans; Macromolecular Substances; Male; Mice; Mice, Transgenic; Mutation; Phosphorylation; Sarcosine; Sex Factors; Solubility; tau Proteins; Tauopathies

2002
Phosphorylated p38MAPK specific antibodies cross-react with sarkosyl-insoluble hyperphosphorylated tau proteins.
    Journal of neurochemistry, 2004, Volume: 90, Issue:4

    Topics: Age Factors; Alzheimer Disease; Animals; Antibodies; Antibody Specificity; Blotting, Western; Brain; Cross Reactions; Disease Models, Animal; Female; Humans; Mice; Mice, Transgenic; Mitogen-Activated Protein Kinases; Neurons; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Precipitin Tests; Sarcosine; Solubility; Spinal Cord; tau Proteins; Tauopathies

2004
The potential for beta-structure in the repeat domain of tau protein determines aggregation, synaptic decay, neuronal loss, and coassembly with endogenous Tau in inducible mouse models of tauopathy.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2008, Jan-16, Volume: 28, Issue:3

    Topics: Age Factors; Animals; Cell Death; Detergents; Disease Models, Animal; Gene Expression; Humans; Mice; Mice, Transgenic; Microscopy, Electron, Transmission; Mutation; Neurofibrillary Tangles; Neurons; Phosphorylation; Protein Structure, Tertiary; Sarcosine; Silver Staining; Synapses; tau Proteins; Tauopathies

2008